Diabetes and advanced glycation endproducts

By H. Vlassara, M. Palace. Journal of Internal Medicine, 2002

729 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/ccbd589ea5ef4bb8a0e463129f5385db13e2206b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. T. Grune

Citations in the corpus

• Role of advanced glycation end products in cellular signaling (2014, background): “There exist strong evidence that under basal conditions AGE-R1/OST-48 and AGE-R3/galectin-3 have a high affinity to bind AGEs [131].”
• Advanced glycoxidation end products in commonly consumed foods. (2004, background): “dvanced glycoxidation end products (AGEs) constitute a group of heterogeneous moieties produced endogenously from the nonenzymatic glycation of proteins, lipids, and nucleic acids ( 1 ,2).”